A national education program for pharmacists funded by the Australian Government under the Quality Use of Diagnostics, Therapeutics and Pathology program.[/caption]
While the evidence bases for both CMs and Schedule 3 sleep aids are unlikely to immediately change, a core practice consideration is the risk-benefit profile of the respective non-prescription sleep aids for the individual patient. 
Is it really insomnia?
Knowledge to practice 
While vaccine availability is increasing across the country, acceptance is waning among certain groups.
Pharmacists are experiencing increasing levels of burnout due to COVID-19 related stressors, according to the results of a new national survey.
With COVID-19 continuing to dominate news headlines more than a year after the World Health Organization declared a pandemic, PSA has urged people not to forget their annual influenza vaccination.
The state's major parties have committed to allowing pharmacist immunisers to access the National Immunisation Program (NIP) for the first time.
Pfizer is now the COVID-19 vaccine of choice for some at-risk patients and those under 50 years of age in priority groups.
It can be tough attracting colleagues away from city lifestyles, but there's more to be found 'out there', as these pharmacists discovered.
Eligible patients in New South Wales (NSW) will soon be able to receive their influenza vaccines from community pharmacists under the National Immunisation Program (NIP).
Two pharmacists talk life in the Defence Force and the importance of honouring our veterans.
In a new monthly series, Australian Pharmacist will speak to the experts and answer some of your most frequently asked questions.
For the late Patrick Timbs MPS, pharmacy provided a lifelong vocation and the chance to be a passionate community advocate.
